Frederick, MD, United States of America

Ulrich Baxa

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 17.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Ulrich Baxa: Innovator in Immunology and Biotechnology

Introduction

Ulrich Baxa is a prominent inventor based in Frederick, MD (US), known for his significant contributions to the fields of immunology and biotechnology. With a total of six patents to his name, Baxa has made remarkable advancements in the development of therapeutic solutions for infectious diseases.

Latest Patents

Among his latest patents is the invention related to Prefusion RSV F proteins and their use. This patent provides embodiments of a recombinant Respiratory Syncytial Virus (RSV) F ectodomain trimer that is stabilized in a prefusion conformation. The patent also discloses nucleic acids encoding the RSV F ectodomain trimer and methods for producing it. Furthermore, it outlines methods for inducing an immune response in a subject, which can be utilized for treating or preventing RSV infections by administering a therapeutically effective amount of the recombinant RSV F ectodomain trimer.

Another notable patent is for self-assembling insect ferritin nanoparticles. This invention discloses recombinant insect ferritin nanoparticles that can display two different trimeric antigens at an equal ratio. It also includes nucleic acids encoding these nanoparticles and methods for their production. The methods provided aim to elicit an immune response in a subject, showcasing Baxa's commitment to advancing immunological research.

Career Highlights

Ulrich Baxa works for the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His role in this esteemed organization highlights his dedication to public health and innovation in medical research.

Collaborations

Baxa has collaborated with notable colleagues such as Ivelin Georgiev and Michael Gordon Joyce. These partnerships have likely contributed to the success of his research and patent developments.

Conclusion

Ulrich Baxa's innovative work in the field of immunology, particularly through his patents on RSV F proteins and insect ferritin nanoparticles, underscores his impact on biotechnology and public health. His contributions continue to pave the way for advancements in therapeutic solutions for infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…